By inhibiting NNMT, 5-Amino-1MQ has been investigated for its potential to increase intracellular NAD+ levels and modulate lipid metabolism in preclinical settings
Younger individuals with a significant family history or other predisposing factors may warrant earlier or more intensive screening protocols
Information about the products on this website is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease
Tesamorelin + Ipamorelin Stack: How the Dose Differs When tesamorelin is combined with ipamorelin for a synergistic GH release protocol, the dosing follows a graduated structure: Month 1: 20 units per injection (1mg tesamorelin + 0.5mg ipamorelin), 5 days on, 2 days off
Neurological research represents another frontier for BPC-157 investigations
After injury induction, BPC-157 reduced brain lesions, including hemorrhages and edema, and improved the overall recovery of the rats